α-Synuclein is an important drug target for the treatment of Parkinson’s disease (PD), but it is an intrinsically disordered protein lacking typical small-molecule binding pockets. In contrast, the encoding SNCA mRNA has regions of ordered structure in its 5′ untranslated region (UTR). Here, we pres...
Highlights, strengths & weaknesses, commercial applications, and societal impact — written for this paper on demand.
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!